MedTrace Logo

Intramuscular Ketamine Effect on Postnasal Surgery Agitation

NCT05313659 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2023-01-25

No results posted yet for this study

Summary

Emergence agitation (EA) is a common complication after nasal surgery. In this study, we aimed to investigate the effect of intramuscular ketamine on EA following septoplasty and open septorhinoplasty (OSRP) when administered at subanesthetic doses at the end of surgery. Sedation and Agitation scores were recorded using The Richmond agitation-sedation score after extubation.

Conditions

  • Agitation, Emergence

Interventions

DRUG

Ketamine Hydrochloride

intramuscular ketamine hydrochloride at dose of 0.7 mg/kg at the time of turning the inhalational agent off

Sponsors & Collaborators

  • Jordanian Royal Medical Services

    lead OTHER

Principal Investigators

  • Husam A. Almajali, MD · Jordanian Royal Medical Services

  • Ali M. Abu Dalo, MD · Jordanian Royal Medical Services

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-11
Primary Completion
2022-10-20
Completion
2022-10-20

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05313659 on ClinicalTrials.gov